title: Improved serum cholesterol in paediatric patients switched from suppressive lopinavir-based therapy to boosted darunavir or atazanavir: an 18-month retrospective study.
authors.affiliation: Department of Paediatric Infectious Diseases, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: N
authors.initials: N
authors.lastname: Xiang
authors.forename: M
authors.initials: M
authors.lastname: James
authors.forename: S
authors.initials: S
authors.lastname: Walters
authors.forename: A
authors.initials: A
authors.lastname: Bamford
authors.forename: C
authors.initials: C
authors.lastname: Foster
mesh_terms: D000293:Adolescent; D000704:Analysis of Variance; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000069446:Atazanavir Sulfate; D002648:Child; D002784:Cholesterol / Q000097:blood*; D000069454:Darunavir; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D008297:Male; D009842:Oligopeptides; D011725:Pyridines; D012189:Retrospective Studies; D013449:Sulfonamides
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D013449:Sulfonamides; D061466:Lopinavir; D000069446:Atazanavir Sulfate; D002784:Cholesterol; D000069454:Darunavir